Royalty Pharma and J&J partner to develop autoimmune treatment | Stacks 92.1 | The Hits That Power the Party! | Lansing, MI

×

Sign In

Royalty Pharma and J&J partner to develop autoimmune treatment

By Thomson Reuters Mar 30, 2026 | 9:13 AM

March 30 (Reuters) – Royalty Pharma said on Monday it has signed a $500 million research and development ‌agreement with Johnson & Johnson to advance an experimental antibody treatment for autoimmune diseases.

Shares of ‌Royalty Pharma were ⁠up 1.4% in ⁠premarket trading, while those of J&J rose nearly 0.7%.

(Reporting by Kunal Das in Bengaluru; Editing by Diti Pujara)

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.

Lebanese army says soldier killed in Israeli attack in southern Lebanon

Trump threatens to hit Iran infrastructure on Tuesday if Strait remains blocked

Zelenskiy in Syria to meet President Sharaa, sources say

British royals gather for Easter service, with Andrew and his family absent

Boxing-Wilder calls out Joshua after win over Chisora

Vessel with wheat cargo sinks in Sea of Azov, one dead, two missing